Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.
about
Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comparison of Three Different ...... te Improved Assay Sensitivity.
@ast
Comparison of Three Different ...... te Improved Assay Sensitivity.
@en
type
label
Comparison of Three Different ...... te Improved Assay Sensitivity.
@ast
Comparison of Three Different ...... te Improved Assay Sensitivity.
@en
prefLabel
Comparison of Three Different ...... te Improved Assay Sensitivity.
@ast
Comparison of Three Different ...... te Improved Assay Sensitivity.
@en
P2093
P2860
P356
P1476
Comparison of Three Different ...... te Improved Assay Sensitivity.
@en
P2093
AIDS Clinical Trials Group
Bryan R Cobb
Cheryl Jennings
Christina M Lalama
Gavin A Cloherty
Heather J Ribaudo
James W Bremer
John E McKinnon
John W Mellors
Robert W Coombs
P2860
P304
P356
10.1128/JCM.00801-15
P407
P577
2015-06-10T00:00:00Z